58 results
8-K
EX-10.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
17 Oct 23
Entry into a Material Definitive Agreement
7:24pm
related to exposure to Hazardous Materials), including those related to Hazardous Materials or wastes, air emissions and discharges to waste or public
425
mivxscxzy
24 Mar 22
Business combination disclosure
9:09am
8-K
EX-2.1
n1722409op9x n23u74
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
8-K
EX-10.1
jn1vhaey2 jjcgsf8
10 Sep 20
Entry into a Material Definitive Agreement
4:43pm
SC TO-C
EX-2.1
4ft6 657i8sf9a9f6l
10 Aug 20
Information about tender offer
9:50pm
8-K
EX-2.1
h79gszb
10 Aug 20
Tender and Support Agreement
9:48pm
8-K
EX-10.1
bk7q9nft fv1afiqme
9 Sep 11
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.2
4w68zukre
9 Sep 11
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.3
z5s7jv oj24
26 Jan 11
Entry into a Material Definitive Agreement
12:00am